PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Using gold and light to study molecules in water

Researchers at EPFL can now observe biomolecule interactions in a sample of water in real time; A major step for medicine

2013-07-31
(Press-News.org) Thanks to a new device that is the size of a human hair, it is now possible to detect molecules in a liquid solution and observe their interactions. This is of major interest for the scientific community, as there is currently no reliable way of examining both the behavior and the chemical structure of molecules in a liquid in real time.

Developed at Boston University by Hatice Altug and her student Ronen Adato, the process brings together infrared detection techniques and gold nanoparticles. It could potentially make a whole new class of measurements possible, which would be a critical step in understanding basic biological functions as well as key aspects of disease progression and treatment. "Our technology could prove useful for studying the behaviour of proteins, medicines and cells in the blood or pollutants in water", says Hatice Altug.

Now a researcher at EPFL Dr. Altug has had her results published in Nature Communications.

Like a guitar string

The device is based on a well-known detection technique called infrared absorption spectroscopy. Infrared light can already be used to detect elements: The beam excites the molecules, which start to vibrate in different ways depending on their size, composition and other properties. "It's like a guitar string vibrating differently depending on its length," explains Hatice Altug. The unique vibration of each type of molecule acts as a signature for that molecule.

This technique works very well in dry environments but not at all well in aqueous environments. "A large number of molecules need to be present for them to be detected. It's also more difficult to detect molecules in water, as when the beam goes through the solution, the water molecules vibrate as well and interfere with the target molecule's signature," explains Dr. Altug.

Using nanoparticles to capture and illuminate molecules

To get around these obstacles, the researchers have developed a system capable of isolating the target molecules and eliminating interferences.

The size of a penny, the device is made up of miniature fluidic chambers, which are covered on one side with nano-scale gold particles with surprising properties. "We cover the surface of the nanoparticles with, for example, antibodies, in order to make a specific protein or chemical stick to them," explains the researcher. "Once the solution containing the targeted elements is introduced into the chamber, the nanoparticles act as molecule catchers." This technique makes it possible to isolate the target molecules from the rest of the liquid.

But this is not the only role the nanoparticles play. They are also capable of concentrating light in nanometer-size volumes around their surface as a result of plasmonic resonance.

In the chamber, the beam doesn't need to pass through the whole solution. Instead, it is sent straight to the nanoparticle, which concentrates the light. Caught in the trap, the target molecules are the only ones that are so intensely exposed to the photons.

The reaction between the molecules and the infrared photons is extremely strong, which means they can be detected and observed very precisely. "This technique enables us to observe molecules in-situ as they react with elements in their natural environment. This could prove extremely useful for both medicine and biology," states Dr. Altug.

Use in medical research

Another advantage is that the chip is extremely compact and can be connected to microscopes already in use. "We don't need large sample sizes to conduct our analyses," says Ronen Adato.

Going forward, Hatice Altug intends to continue her research with a focus on medical applications. The first tests have been conducted with ordinary antibody molecules, and the analyses now need to be fine-tuned. "I'd really like to work with other life-science researchers, hospitals and biologists. I'm especially interested in using my method in the study of diseases, including cancer and neurological disorders, to observe the effect of certain medicines on diseased cells or to detect disease biomarkers, for example."



INFORMATION:



ELSE PRESS RELEASES FROM THIS DATE:

Electrified sewage: New American Chemical Society video on electricity from wastewater

2013-07-31
Shocking as it may seem, wastewater flushed down toilets and sinks is getting a new life thanks to special fuel cells that use it to produce electricity, according to the latest video in the American Chemical Society's (ACS') Bytesize Science series. Produced by the world's largest scientific society, the video is at http://www.BytesizeScience.com. Bruce E. Logan, Ph.D., featured in the video, points out that sewage treatment traditionally has been a big consumer of electricity. With the new fuel cells, that situation could be reversed, with sewage becoming the raw material ...

New therapy improves life span in melanoma patients with brain metastases, SLU researchers find

2013-07-31
ST. LOUIS -- In a retrospective study, Saint Louis University researchers have found that patients with melanoma brain metastases can be treated with large doses of interleukin-2 (HD IL-2), a therapy that triggers the body's own immune system to destroy the cancer cells. The study that was recently published in Chemotherapy Research and Practice, reviews cases of eight patients who underwent this therapy at Saint Louis University. John Richart, M.D., associate professor of internal medicine at SLU and principal investigator of the study, first treated a patient with ...

Cross-country collaboration leads to new leukemia model

2013-07-31
Eight years ago, two former Stanford University postdoctoral fellows, one of them still in California and the other at the Harvard Stem Cell Institute (HSCI) in Cambridge, began exchanging theories about why patients with leukemia stop producing healthy blood cells. What was it, they asked, that caused bone marrow to stop producing normal blood-producing cells? And after almost a decade of bicoastal collaboration, Emmanuelle Passegué, now a professor in the Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research at the University of California, San ...

Brain maps to benefit epileptic surgery

2013-07-31
A brain imaging research team led by Simon Fraser University neuroscientist Dr. Ryan D'Arcy has found a new way to help surgeons more accurately plan for surgical treatment in epilepsy. The results of a recent study using magnetoencephalography (MEG) have been published in the field's highest impact journal, Human Brain Mapping. To showcase the study, the journal highlighted the novel images of MEG activity on the August 2013 cover. D'Arcy and his team used MEG technology to produce detailed spatial maps of critical language functions in order to better enable pre-operative ...

Genetic link to gestational diabetes

2013-07-31
CHICAGO --- New Northwestern Medicine® research on the genetics of diabetes could one day help women know their risk for developing gestational diabetes before they become pregnant -- and lead to preventive measures to protect the health of offspring. Gestational diabetes affects 18 percent of pregnancies but usually disappears when a pregnancy is over. Babies born to women with gestational diabetes are typically larger at birth, which can lead to complications during delivery. They are at an increased risk of developing metabolic diseases, such as diabetes, in childhood ...

Oregon lab changes game for synthesizing new materials

2013-07-31
EUGENE, Ore. -- University of Oregon chemist David C. Johnson likens his lab's newly published accomplishments to combining two flavors of ice cream -- vanilla and chocolate -- and churning out thousands of flavors to appeal to any taste bud. In reality, though, he is referring to his game-changing approach to synthesize thousands of new compounds with ultra low thermal conductivity and other unusual properties quickly instead of the traditional and time-consuming preparative approach that is limited to just a few thermodynamically stable compounds. In a paper placed ...

HIV answers raise new ethical questions

2013-07-31
The Food and Drug Administration's approval last year of the drug Truvada for prevention of HIV infection was a milestone in the fight against HIV/AIDS, but experts are cautioning that it is only the beginning of new ethical concerns for health care professionals, policy makers, researchers and those taking Truvada to prevent HIV infection. "For the first time, we will have a large number of individuals who are not infected with HIV taking medication for HIV, which introduces ethical concerns of well-being and justice," says Jeremy Sugarman, Deputy Director for Medicine ...

Berkeley Lab researchers discover universal law for light absorption in 2D semiconductors

2013-07-31
From solar cells to optoelectronic sensors to lasers and imaging devices, many of today's semiconductor technologies hinge upon the absorption of light. Absorption is especially critical for nano-sized structures at the interface between two energy barriers called quantum wells, in which the movement of charge carriers is confined to two-dimensions. Now, for the first time, a simple law of light absorption for 2D semiconductors has been demonstrated. Working with ultrathin membranes of the semiconductor indium arsenide, a team of researchers with the U.S. Department of ...

Navy turns to UAVs for help with radar, communications

2013-07-31
ARLINGTON, Va.—Scientists recently launched unmanned aerial vehicles (UAVs) from a research vessel in a significant experiment that could help boost the Navy's radar and communications performance at sea. Sailing off Virginia Beach, Va., from July 13 to 18, the Office of Naval Research's (ONR) Research Vessel (R/V) Knorr explored ocean and atmospheric weather variations that can change the angle that radar and radio waves bend, making it more difficult for ships to remain undetected and hindering their ability to communicate or locate adversaries. Sponsored by ONR's ...

Penn: New variants at gene linked to kidney disease, sleeping sickness resistance

2013-07-31
A new study led by University of Pennsylvania researchers involves a classic case of evolution's fickle nature: a genetic mutation that protects against a potentially fatal infectious disease also appears to increase the risk of developing a chronic, debilitating condition. Such a relationship exists between malaria and sickle cell anemia. Individuals who carry a gene to resist the former are carriers for the latter. And recently scientific evidence has suggested that individuals who are resistant to human African trypanosomiasis, or sleeping sickness, are predisposed ...

LAST 30 PRESS RELEASES:

Making lighter work of calculating fluid and heat flow

Normalizing blood sugar can halve heart attack risk

Lowering blood sugar cuts heart attack risk in people with prediabetes

Study links genetic variants to risk of blinding eye disease in premature infants

Non-opioid ‘pain sponge’ therapy halts cartilage degeneration and relieves chronic pain

AI can pick up cultural values by mimicking how kids learn

China’s ecological redlines offer fast track to 30 x 30 global conservation goal

Invisible indoor threats: emerging household contaminants and their growing risks to human health

Adding antibody treatment to chemo boosts outcomes for children with rare cancer

Germline pathogenic variants among women without a history of breast cancer

Tanning beds triple melanoma risk, potentially causing broad DNA damage

Unique bond identified as key to viral infection speed

Indoor tanning makes youthful skin much older on a genetic level

Mouse model sheds new light on the causes and potential solutions to human GI problems linked to muscular dystrophy

The Journal of Nuclear Medicine ahead-of-print tip sheet: December 12, 2025

Smarter tools for peering into the microscopic world

Applications open for funding to conduct research in the Kinsey Institute archives

Global measure underestimates the severity of food insecurity

Child survivors of critical illness are missing out on timely follow up care

Risk-based vs annual breast cancer screening / the WISDOM randomized clinical trial

University of Toronto launches Electric Vehicle Innovation Ontario to accelerate advanced EV technologies and build Canada’s innovation advantage

Early relapse predicts poor outcomes in aggressive blood cancer

American College of Lifestyle Medicine applauds two CMS models aligned with lifestyle medicine practice and reimbursement

Clinical trial finds cannabis use not a barrier to quitting nicotine vaping

Supplemental nutrition assistance program policies and food insecurity

Switching immune cells to “night mode” could limit damage after a heart attack, study suggests

URI-based Global RIghts Project report spotlights continued troubling trends in worldwide inhumane treatment

Neutrophils are less aggressive at night, explaining why nighttime heart attacks cause less damage than daytime events

Menopausal hormone therapy may not pose breast cancer risk for women with BRCA mutations

Mobile health tool may improve quality of life for adolescent and young adult breast cancer survivors

[Press-News.org] Using gold and light to study molecules in water
Researchers at EPFL can now observe biomolecule interactions in a sample of water in real time; A major step for medicine